Kaj pomeni »Počisti«?
Žival ne nosi mutacije. To ne bo razvilo bolezni in ga ne bo posredoval naprej.
pes Maligna hipertermija pri psih (MH)
Discover the importance of DNA testing for Canine Malignant Hyperthermia (MH) in dogs. This genetic disorder can lead to severe reactions during anesthesia, placing your furry friend at risk. By identifying the MH gene mutation through a simple DNA test, pet owners can make informed decisions about their dog's health and safety. Early detection allows for proactive management, ensuring a safer experience during veterinary procedures. Investing in a DNA test for Canine Malignant Hyperthermia can ultimately save lives and enhance your dog's well-being. Consult your veterinarian today to learn more about this vital genetic screening. Protect your pup with knowledge and peace of mind!
Okrajšava: MH
Analizirana mutacija: RYR1 c.1643T>C
dedovanje: Avtosomno dominanten
akronim
MH
Opazovana frekvenca
Klinična resnost
Klinična klasifikacija
Presnovne bolezni
Analizirana mutacija
RYR1 c.1643T>C
p.(V548A)
p.(V548A)
Način dedovanja
Avtosomno dominanten
Povzetek testa:
Canine Malignant Hyperthermia (MH) is a rare genetic disorder triggered by certain anesthetic agents in dogs. It leads to a severe and uncontrolled increase in body temperature, muscle rigidity, and metabolic disturbances. The condition is often linked to mutations in the ryanodine receptor gene. Prompt recognition and immediate treatment are crucial to prevent serious complications or death. Preventive measures include genetic testing and avoiding specific anesthetics in at-risk breeds.
Na voljo iz paketa: Basic
Ta DNK test je vključen od našega paketa Basic — in je tudi del paketov Basic, Standard, Advanced, Complete.
Oglejte si pakete testov DNK →Izberite paket, ki najbolje ustreza vaši vzrejni ali zdravstveni strategiji vaših živali.
Introduction to Canine Malignant Hyperthermia (MH)
Canine Malignant Hyperthermia (MH) is a rare but serious genetic disorder that affects certain dog breeds. It is characterized by an abnormal and severe response to specific stressors, such as anesthesia or extreme heat, leading to a rapid increase in body temperature and metabolic crisis. If not recognized and treated promptly, MH can be fatal for the affected dog.
Understanding the Condition
Malignant Hyperthermia in dogs is caused by a hereditary defect in the regulation of calcium within muscle cells. This defect leads to uncontrolled muscle contractions and a significant increase in metabolic activity, resulting in a rapid rise in core body temperature. Symptoms often include muscle rigidity, rapid breathing, increased heart rate, and a sudden onset of hyperthermia. The condition is often triggered by certain anesthetic agents or stress, making perioperative management critical.
Genetic Basis of Canine MH
The disorder is inherited in a manner similar to that observed in humans, with specific genetic mutations affecting calcium regulation pathways. Dogs carrying these mutations are predisposed to developing MH when exposed to triggering factors. Identifying affected dogs through DNA testing allows breeders and veterinarians to make informed decisions to prevent the spread of the disorder and to implement appropriate management strategies for affected animals.
The Role of DNA Testing
DNA testing for canine MH involves analyzing specific genetic markers associated with the disorder. This test provides valuable information about an individual dog's genetic status, helping to identify carriers or affected animals. Early detection through DNA testing can assist in making preventative choices, such as avoiding certain medications or stressful situations that could trigger a crisis, thereby safeguarding the health and well-being of the dog.
Importance of Diagnosis and Management
Accurate diagnosis of MH through DNA testing is essential for effective management. Dogs identified as at risk can be provided with tailored anesthetic protocols, monitored closely during procedures, and kept in a stress-free environment. Additionally, knowing a dog’s genetic status helps inform breeding decisions to reduce the prevalence of the disorder within a breed population.
Pasma, priznana za test: Maligna hipertermija pri psih (MH)
- Bearded Collie
- Border Collie
- Doberman Pinscher
- Farm Collie
- German Shepherd Dog
- Labrador Retriever
- Old Farm Collie
- Rough Collie
- Scottish Collie
- Scottish Rough Collie
- Scottish Smooth Collie
- Smooth Collie
🧬 Interpretation of genotypes MH
Genotip
Stanje
🟡 N/N
Brez prevoznika – brez tveganja
🟡 N/MH
Prevoznik – v nevarnosti
❌ MH/MH
Prizadeti – ogroženi
Pogosta vprašanja: razumevanje interpretacije
Je "prevoznik" resen?
Ne. Žival je na splošno zdrava, vendar lahko prenese mutacijo na svojo potomci.
Kaj pa, če je žival "prizadeta"?
Nosi dve mutirani kopiji. Klinični znaki so pričakovani glede na bolezen. Ne sme se vzrejati.
Zakaj obstajajo razlike med moškim in žensko?
Nekatere bolezni so povezane s spolom, zato se njihov izraz razlikuje glede na spol živali.
Napoved potomcev
N/N (neprevoznik)
N/MH (Nosilec)
MH/MH (Prizadeti)
Pogosta vprašanja o testu DNK
Kaj ugotovi ta DNK test?
This DNA test detects the mutation associated with Canine Malignant Hyperthermia (MH) in order to identify clear, carrier, or at-risk animals.
Zakaj testirati plemensko žival?
Testiranje DNK pomaga rejcem pri načrtovanju varnejših parjenj in zmanjšanju tveganja prenosa mutacije na potomce.
Kakšen je način dedovanja tega testa?
Način dedovanja, sporočen za ta test, je avtosomno dominanten.
Katero mutacijo analiziramo v tem testu?
This test analyses the mutation RYR1 c.1643T>C.
Ali je žival prenašalka nujno prizadeta?
Ni nujno. Razlaga je odvisna od vzorca dedovanja in nastalega genotipa.
Reference
Roberts M C, Mickelson J R, Patterson E E, Nelson T E, Armstrong P J, Brunson D B, Hogan K. Autosomal dominant canine malignant hyperthermia is caused by a mutation in the gene encoding the skeletal muscle calcium release channel (RYR1). Anesthesiology. 2001 Sep;95(3):716-25. doi: 10.1097/00000542-200109000-00026.